Autopsy report · NCT05431244

Pilot Study of Antiviral Treatment in Combination With Low-dose Gemcitabine in EBV-associated Gastric Cancer (EBVaGC)

“Research withdrawal before patient registration due to difficulty in continuing research”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Samsung Medical Center

Sponsor type

University, hospital or other

Conditions

Gastric Cancer

Interventions

Antiviral treatment in combination with low-dose gemcitabine

Participants

0

Sites

1

Countries

South Korea

Trials that died the same way

• Effectiveness and Safety of Early Treatment With Infliximab for Hip Arthritis Associated With Ankylosing Spondylitis (AS) (P06451)
  “No patient enrolled after 6 months from the start. The decision to withdraw the study was based on a feasibility reevaluation conducted with investigators.” (72% match in meaning)
• Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma
  “Withdrawn: study halted prematurely, prior to enrollment of first participant” (67% match in meaning)
• Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI
  “Study was withdrawn due to lack of patient enrollment.” (67% match in meaning)
• Group Education & Lifestyle Modification's Impact on Weight Loss & Quality Life of Patients with OA
  “Investigator decision to withdraw study.” (66% match in meaning)
• Inflammatory Bowel Disease(IBD), Treatment Response
  “Recruitment of patients for this clinical trial has been withdrawn due to logistical challenges and the inability to enroll a sufficient number of participants meeting the specific eligibility criteria within the projected timeline.” (65% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.